FundedIQ
Biotechnology

Codagenix: Funding, Investors & Team (Oct 2026)

Codagenix specializes in creating live-attenuated viral vaccines that contain targeted antigens within a weakened viral structure. These vaccines make use of Synthetic Attenuated Virus Engineering (SAVE), a process rooted in synthetic biology where the entire genome is deliberately modified to produce an effective vaccine strain.

codagenix.com LinkedIn Farmingdale, United States 11-50 employees
Biotechnology Genetics Medical
Total raised
$35.3M
Rounds
3
Latest
Undisclosed round
Oct 2023

Codagenix has raised $35.3M across 3 funding rounds on record, the most recent an undisclosed round of $5.9M announced in Oct 2023.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Codagenix Company Profile and Key Stats

Total funding raised
$35.3M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$5.9M in Oct 2023
Employees
11-50
reported band
Headquarters
Farmingdale, United States

Latest funding round on record: Oct 2023.

Codagenix Funding Rounds

Date
Round
Amount
Undisclosed round
$5.9M
Series B
$25.0M
Grant
$4.4M

Codagenix raised $4.4M in a Grant announced in Aug 2022.

6 months later, a Series B of $25.0M was announced in Feb 2023.

8 months later, an undisclosed round of $5.9M was announced in Oct 2023.

Codagenix Founders and Leadership Team

Name
Role
Contact
Eckard Wimmer
Founder
—

No contact details are on record for this team yet.

Codagenix Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Codagenix's latest round of $5.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Codagenix in Biotechnology and Farmingdale

Companies Similar to Codagenix

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Codagenix Funding FAQs

What does Codagenix do?

Codagenix specializes in creating live-attenuated viral vaccines that contain targeted antigens within a weakened viral structure. These vaccines make use of Synthetic Attenuated Virus Engineering (SAVE), a process rooted in synthetic biology where the entire genome is deliberately modified to produce an effective vaccine strain.

How much funding has Codagenix raised?

Codagenix has raised $35.3M across 3 rounds on record. The most recent is an undisclosed round of $5.9M announced in Oct 2023.

When did Codagenix last raise funding?

Codagenix's most recent funding round on record is an undisclosed round of $5.9M, announced in Oct 2023.

Who founded Codagenix?

FundedIQ lists Eckard Wimmer (Founder) at Codagenix.

Where is Codagenix headquartered?

Codagenix is based in Farmingdale, New York, United States.

How many employees does Codagenix have?

Codagenix is in the 11-50 employee band.

How does Codagenix's funding compare to other Biotechnology startups?

Codagenix's latest round of $5.9M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Codagenix Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Codagenix is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.